IL17A and metabolic dysfunction-associated steatotic liver disease: Thus, IL-17 axis activation during MCDD-driven NAFLD pathogenesis may regulate both CXCL10 production and hepatic T cell infiltration; however, whether T cells or resident hepatic cells produce CXCL10 in this context remains undefined.